HIGHLIGHTS
- who: Juan J. Badimon and collaborators from the Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA have published the paper: Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease, in the Journal: (JOURNAL)
- what: This Article aims to review the different strategies directed towards FXI-inhibition with a brief summation of the agents in clinical development and to comment on the therapeutic areas that could be explored for potential indications. This study reported low overall incidence of adverse events with no evidence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.